ctrl K

Onconova Therapeutics Inc... (ONTX)

NASDAQ: ONTX · Real-Time Price · USD

1.00

0.00 (0.00%)

At close: Apr 02, 2024, 8:00 PM

Onconova Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	226K	226K	226K	231K	2.18M	1.23M	787K	5.55M
Cost of Revenue	-226B	14K	14K	n/a	n/a	n/a	n/a	n/a
Gross Profit	226B	212K	212K	231K	2.18M	1.23M	787K	5.55M
Operating Income	-20.3M	-19.63M	-16.5M	-24.99M	-21.7M	-23.28M	-25.74M	-23.7M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-18.95M	-18.96M	-16.16M	-25.15M	-21.49M	-20.53M	-24.08M	-19.65M
Net Income	-18.95M	-18.3M	-15.83M	-25.16M	-21.5M	-20.57M	-24.09M	-19.67M
Selling & General & Admin	9.09M	8.45M	9.43M	8.33M	8.35M	7.59M	7.41M	9.18M
Research & Development	11.43M	11.41M	7.3M	16.9M	15.54M	16.92M	19.12M	20.07M
Other Expenses	1.35M	663K	12K	48K	143K	1.15M	30K	n/a
Operating Expenses	20.52M	19.85M	16.72M	25.22M	23.88M	24.51M	26.52M	29.25M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	20.52M	19.85M	16.72M	25.22M	23.88M	24.51M	26.52M	29.25M
Income Tax Expense	n/a	-663K	-335K	4K	10K	-124K	13K	14K
Shares Outstanding (Basic)	20.99M	20.91M	16.83M	11.6M	958.97K	385.48K	40K	19.67K
Shares Outstanding (Diluted)	20.99M	20.91M	16.83M	11.6M	958.97K	385.48K	40K	19.67K
EPS (Basic)	-0.9	-0.88	-0.94	-2.17	-22.42	-53.37	-602.28	-999.64
EPS (Diluted)	-0.9	-0.88	-0.94	-2.17	-22.42	-53.37	-602.28	-999.64
EBITDA	-20.28M	-19.63M	-16.82M	-24.79M	-21.76M	-24.88M	-27.36M	-27.66M
EBIT	n/a	-18.98M	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	16K	14K	-321K	208K	-63K	55K	88K	96K